Analysing population-based cancer survival – settling the controversies

BackgroundThe relative survival field has seen a lot of development in the last decade, resulting in many different and even opposing suggestions on how to approach the analysis.MethodsWe carefully define and explain the differences between the various measures of survival (overall survival, crude mortality, net survival and relative survival ratio) and study their differences using colon and prostate cancer data extracted from the national population-based cancer registry of Slovenia as well as simulated data.ResultsThe colon and prostate cancer data demonstrate clearly that when analysing population-based data, it is useful to split the overall mortality in crude probabilities of dying from cancer and from other causes. Complemented by net survival, it provides a complete picture of cancer survival in a given population. But when comparisons of different populations as defined for example by place or time are of interest, our simulated data demonstrate that net survival is the only measure to be used.ConclusionsThe choice of the method should be done in two steps: first, one should determine the measure of interest and second, one should choose among the methods that estimate that measure consistently.

[1]  P. Stattin,et al.  How can we make cancer survival statistics more useful for patients and clinicians: An illustration using localized prostate cancer in Sweden , 2013, Cancer Causes & Control.

[2]  H. Putter,et al.  Competing risks in epidemiology: possibilities and pitfalls. , 2012, International journal of epidemiology.

[3]  E. Feuer,et al.  Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. , 2000, Statistics in medicine.

[4]  T. Hakulinen,et al.  Choosing the net survival method for cancer survival estimation. , 2015, European Journal of Cancer.

[5]  Janez Stare,et al.  On Estimation in Relative Survival , 2012, Biometrics.

[6]  Enzo Coviello,et al.  Estimating Net Survival using a Life-Table Approach , 2015 .

[7]  Henrik Møller,et al.  Quantifying differences in breast cancer survival between England and Norway. , 2011, Cancer epidemiology.

[8]  Coraline Danieli,et al.  Cancer net survival on registry data: Use of the new unbiased Pohar‐Perme estimator and magnitude of the bias with the classical methods , 2013, International journal of cancer.

[9]  Janez Stare,et al.  Relative survival analysis in R , 2006, Comput. Methods Programs Biomed..

[10]  F. Ederer,et al.  The relative survival rate: a statistical methodology. , 1961, National Cancer Institute monograph.

[11]  T. Hakulinen,et al.  Cancer survival corrected for heterogeneity in patient withdrawal. , 1982, Biometrics.

[12]  Karri Seppä,et al.  Comparing net survival estimators of cancer patients , 2016, Statistics in medicine.

[13]  Enzo Coviello,et al.  Estimating and Modeling Relative Survival , 2015 .

[14]  Paul C. Lambert,et al.  Comparison of different approaches to estimating age standardized net survival , 2015, BMC Medical Research Methodology.

[15]  P. Lambert,et al.  Choosing the relative survival method for cancer survival estimation. , 2011, European journal of cancer.

[16]  Michel Grzebyk,et al.  Net Survival Estimation with Stns , 2014 .

[17]  Laurent Remontet,et al.  Estimating net survival: the importance of allowing for informative censoring , 2012, Statistics in medicine.